FI955238A0 - Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset - Google Patents

Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset

Info

Publication number
FI955238A0
FI955238A0 FI955238A FI955238A FI955238A0 FI 955238 A0 FI955238 A0 FI 955238A0 FI 955238 A FI955238 A FI 955238A FI 955238 A FI955238 A FI 955238A FI 955238 A0 FI955238 A0 FI 955238A0
Authority
FI
Finland
Prior art keywords
aryloxymethyl
oxazolines
alkyl
new
compounds
Prior art date
Application number
FI955238A
Other languages
English (en)
Swedish (sv)
Other versions
FI955238A (fi
Inventor
Christian Jarry
Isabelle Forfar
Jean-Jacques Bosc
Pierre Renard
Elizabeth Scalbert
Beatrice Guardiola
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of FI955238A0 publication Critical patent/FI955238A0/fi
Publication of FI955238A publication Critical patent/FI955238A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI955238A 1994-11-03 1995-11-01 Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset FI955238A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9413087A FR2726558B1 (fr) 1994-11-03 1994-11-03 Nouvelles 5-(aryloxymethyl) oxazolines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
FI955238A0 true FI955238A0 (fi) 1995-11-01
FI955238A FI955238A (fi) 1996-05-04

Family

ID=9468429

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955238A FI955238A (fi) 1994-11-03 1995-11-01 Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset

Country Status (16)

Country Link
US (1) US5686477A (fi)
EP (1) EP0710658B1 (fi)
JP (1) JP3181211B2 (fi)
CN (1) CN1051545C (fi)
AT (1) ATE206414T1 (fi)
AU (1) AU689320B2 (fi)
CA (1) CA2162106C (fi)
DE (1) DE69523011T2 (fi)
DK (1) DK0710658T3 (fi)
ES (1) ES2165410T3 (fi)
FI (1) FI955238A (fi)
FR (1) FR2726558B1 (fi)
NO (1) NO305755B1 (fi)
NZ (1) NZ280387A (fi)
PT (1) PT710658E (fi)
ZA (1) ZA959311B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635668B1 (en) 1998-07-22 2003-10-21 The University Of North Carolina At Chapel Hill Imidazoline receptor binding compounds
BR0206491A (pt) * 2001-01-16 2004-07-06 Eastman Chem Co Concentrado para colorir um poliéster base, composição de poliéster, artigo moldado, e, métodos para preparar uma composição de poliéster colorida, e para colorir uma composição de poliéster
MXPA04001153A (es) * 2001-08-31 2005-02-17 Neurochem Int Ltd Derivados de amidina para tratar la amiloidosis.
PL372695A1 (en) * 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
CA2676944C (en) * 2007-02-15 2016-01-19 F. Hoffmann-La Roche Ag 2-aminooxazolines as taar1 ligands
KR20220147691A (ko) 2013-08-09 2022-11-03 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법
WO2016105449A1 (en) * 2014-12-22 2016-06-30 Seth Lederman Compounds for use as pain therapeutics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3052688A (en) * 1962-09-04 Process for the production of
US3110650A (en) * 1961-09-14 1963-11-12 Szabo Hnos Kessler & Cia S R L Synergistic analgesic compositions
US3278382A (en) * 1962-07-23 1966-10-11 Mcneilab Inc 2-amino-5-aryloxazoline compositions and methods of using same
US3161650A (en) * 1963-01-25 1964-12-15 Mcneilab Inc 2-amino-5-aryloxazoline products
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
US3577428A (en) * 1969-04-14 1971-05-04 Colgate Palmolive Co 2-amino-4-aryloxyalkyl-4-alkyl-2-oxazolines
US3637726A (en) * 1970-04-09 1972-01-25 Dow Chemical Co Substituted-5-((3 4-dihalophenoxy)methyl)-2-oxazoline compounds
US3818028A (en) * 1972-11-01 1974-06-18 Dow Chemical Co Substituted-5-(2,4,6-trihalophenoxy)-methyl)-2-oxazoline compounds
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
FR2645860B1 (fr) * 1989-04-14 1991-07-26 Sarget Lab Nouvelles aryloxymethyl-5 amino-2 oxazolines, syntheses et applications therapeutiques

Also Published As

Publication number Publication date
NO954381L (no) 1996-05-06
CA2162106A1 (fr) 1996-05-04
US5686477A (en) 1997-11-11
DE69523011D1 (de) 2001-11-08
JPH08208630A (ja) 1996-08-13
JP3181211B2 (ja) 2001-07-03
AU689320B2 (en) 1998-03-26
FI955238A (fi) 1996-05-04
DK0710658T3 (da) 2001-11-26
NO954381D0 (no) 1995-11-02
NZ280387A (en) 1996-07-26
CN1051545C (zh) 2000-04-19
ATE206414T1 (de) 2001-10-15
AU3459395A (en) 1996-05-09
CN1129697A (zh) 1996-08-28
PT710658E (pt) 2002-02-28
EP0710658A1 (fr) 1996-05-08
FR2726558B1 (fr) 1996-12-06
EP0710658B1 (fr) 2001-10-04
FR2726558A1 (fr) 1996-05-10
ES2165410T3 (es) 2002-03-16
NO305755B1 (no) 1999-07-19
DE69523011T2 (de) 2002-07-11
ZA959311B (en) 1996-05-29
CA2162106C (fr) 2001-04-10

Similar Documents

Publication Publication Date Title
BR9703447A (pt) Novos compostos 3-(piperid-4-il)-1,2-benzisoxazol e 3-(piperazin-4-il) 1,2-benzisoxazol processos para a preparação dos mesmos e composições farmacêuticas contendo os mesmo
DK234388A (da) 1,4-dihydropyridin-forbindelser, farmaceutiske praeparater indeholdende disse og deres anvendelse til deres fremstilling af laegemidler samt beskyttede derivater deraf til anvendelse som udgangsmateriale ved deres fremstilling
ES521125A0 (es) Procedimiento para preparar espiro (piperidino-oxobenzoxazinas) substituidas en posicion 1 anti-hipertensivas.
FI955238A0 (fi) Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI933719A0 (fi) 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol
NO996284L (no) Nye imidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
IL100430A (en) Pharmaceutical compositions containing 2-phenyl- (ethyl or propyl)-2- (imidazol-1-yl) methyl-4- (phenylthio or phenoxy) methyl-1,3-dioxolane derivatives, certain such novel compounds and their preparation
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
NO996285L (no) Nye spiroimidazolinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
NO972942L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
HUT65376A (en) Process for preparing n,n',n-trisubstituted 5-(diamino-methylene)-1,3-dioxane-4,6-diones and pharmaceutical compositions containing them as active ingredient
HUP9903074A2 (hu) 2-(3H)-Oxazolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
HF Priority information amended